U.S. Markets closed

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
197.87+4.10 (+2.12%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3200.00
52 Week Low 393.48
50-Day Moving Average 3167.87
200-Day Moving Average 3145.74

Share Statistics

Avg Vol (3 month) 3364.04k
Avg Vol (10 day) 3755.15k
Shares Outstanding 544.8M
Implied Shares Outstanding 6N/A
Float 37.35M
% Held by Insiders 11.74%
% Held by Institutions 199.80%
Shares Short (Apr 14, 2021) 42.02M
Short Ratio (Apr 14, 2021) 43.99
Short % of Float (Apr 14, 2021) 44.59%
Short % of Shares Outstanding (Apr 14, 2021) 44.51%
Shares Short (prior month Mar 14, 2021) 42.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Sep 22, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 34.71%
Operating Margin (ttm)39.84%

Management Effectiveness

Return on Assets (ttm)8.66%
Return on Equity (ttm)16.67%

Income Statement

Revenue (ttm)1.48B
Revenue Per Share (ttm)33.56
Quarterly Revenue Growth (yoy)23.70%
Gross Profit (ttm)1.38B
EBITDA 640.9M
Net Income Avi to Common (ttm)514.8M
Diluted EPS (ttm)11.54
Quarterly Earnings Growth (yoy)87.80%

Balance Sheet

Total Cash (mrq)1.84B
Total Cash Per Share (mrq)41.19
Total Debt (mrq)820M
Total Debt/Equity (mrq)24.15
Current Ratio (mrq)6.70
Book Value Per Share (mrq)76.28

Cash Flow Statement

Operating Cash Flow (ttm)755.7M
Levered Free Cash Flow (ttm)662.89M